Frank Steven bought BCRX
November 28, 2025 · Form 4 insider transaction
Frank Steven bought 1,566 shares of BioCryst Pharmaceuticals, Inc. at $7.18 per share, a transaction worth $11.2K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,566
Price
$7.18
Total value
$11.2K
InsiderFrank Steven
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateNovember 28, 2025
Filing dateDecember 2, 2025
Shares owned after17,618
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Shares of Common Stock issued to the reporting person in lieu of 100% of the quarterly cash Board Member retainer of $11,250.